Physician profile
Michael Patrick Markowitz
NPI 1063941698
$12,770.11
in general payments reported to CMS, 2019-2025
21 companies · $2,939 in 2025
The $2,939 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $100 · 2023: $2,373 · 2024: $7,358 · 2025: $2,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,024 · Travel and Lodging: $3,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,023.81 |
| Travel and Lodging | $3,646.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,104.17 | 2023-2025 | Stealthstation S8 Platform, Medtronic Reusable Instruments, Catalyft Pl Expandable Interbody System |
| Stryker Corporation | $2,135.46 | 2024-2025 | Everest Spinal System, Cascadia Interbody System, N/A |
| Alphatec Spine, INC | $1,471.51 | 2023-2025 | Lif, Other - Miscellaneous, Invictus Mis |
| Nuvasive, INC. | $1,404.79 | 2023 | Xlif, Tlif, Acp |
| Painteq LLC | $226.24 | 2023 | Painteq |
| Globus Medical, INC. | $216.51 | 2025 | Hedron, Xlif |
| Spinal Elements, INC. | $154.58 | 2023 | |
| Aesculap Implant Systems, LLC | $151.79 | 2023 | Activl |
| Orthofix Medical, INC. | $136.87 | 2023 | Northstar |
| Zimvie INC. | $133.43 | 2024 | |
| Theragen, INC. | $128.00 | 2025 | Actastim-S |
| Centinel Spine, LLC | $106.65 | 2023 | Prodisc C Vivo |
| Seaspine Orthopedics Corporation | $100.00 | 2022 | |
| Providence Medical Technology, INC. | $70.64 | 2024 | |
| Bioventus LLC | $63.81 | 2024 | Bonescalpel & Sonicone (O.R.) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $51.74 | 2024-2025 | Celleraterx, Celleraterx |
| Endo USA, INC. | $34.90 | 2025 | Xiaflex |
| Depuy Synthes Sales INC. | $24.21 | 2025 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Ferring Pharmaceuticals INC. | $20.98 | 2025 | Euflexxa |
| Carlsmed, INC. | $18.00 | 2025 | Aprevo |
| Amgen INC. | $15.83 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Markowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.